BLSMNASDAQ·USD·Closed·Healthcare · Biotechnology
BlossomHill Therapeutics, Inc.
$20.86−$0.65 · −3.02%day vs prior
Mkt Cap · USD
606.63M
P/E · TTM
-19.3
Div Yield · ann
–
52-week
$15.25 – $23.37
at 69% of range
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.
Loading chart data...
Signal state